Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for liver regeneration after major resection
NCT02555293Phase 2Terminated
- Sponsor
- RWTH Aachen University
- Start
- Feb 2016
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in liver failure, systemic infection, sponsored by RWTH Aachen University. Started Feb 2016; status: terminated.
02
Drugs
rifaximin
03
Conditions
liver failuresystemic infection
Beyond the preview
Go deeper on NCT02555293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555293.